Knight Therapeutics Inc.

Knight Therapeutics Inc. acquires, licenses, and markets a diverse oncology and specialty drug portfolio, including Trelstar, Vidaza, and Bijuva, across Canada and Latin America, while investing in life‑science ventures to drive growth.

Headquarters: Canada (CAN)

Website: Visit Site 🔗
Type: Corporation

Company Profile

Sector: Manufacturing
Industry: Pharmaceutical Manufacturing

Employees: 745
HQ: Montreal

Unlock the full potential.

Get access to Relative P/E Ratio Valuation Histogram.

Upgrade

Traded Instruments

+ Add Instrument 1

Symbol	Name	Type	Exchange	Currency	ISIN	Status	Actions
GUD	Knight Therapeutics Inc. Cap: 0.6B	EQUITY	TOR	CAD	CA4990531069	Active	📈